BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mooij CF, van Herwaarden AE, Sweep FC, Roeleveld N, de Korte CL, Kapusta L, Claahsen-van der Grinten HL. Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency. Journal of Pediatric Endocrinology and Metabolism 2017;30. [DOI: 10.1515/jpem-2017-0068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Mooij CF, Pourier MS, Weijers G, de Korte CL, Fejzic Z, Claahsen-van der Grinten HL, Kapusta L. Cardiac function in paediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency. Clin Endocrinol 2018;88:364-71. [DOI: 10.1111/cen.13529] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Al Alawi AM, Nordenström A, Falhammar H. Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency. Endocrine 2019;63:407-21. [PMID: 30719691 DOI: 10.1007/s12020-018-01835-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
3 Hashemi Dehkordi E, Khaheshi S, Mostofizadeh N, Hashemipour M. Cardiovascular Risk Factors in Children and Adolescents with Congenital Adrenal Hyperplasia. Adv Biomed Res 2021;10:19. [PMID: 34476227 DOI: 10.4103/abr.abr_219_20] [Reference Citation Analysis]
4 Ljubicic ML, Madsen A, Juul A, Almstrup K, Johannsen TH. The Application of Principal Component Analysis on Clinical and Biochemical Parameters Exemplified in Children With Congenital Adrenal Hyperplasia. Front Endocrinol (Lausanne) 2021;12:652888. [PMID: 34531821 DOI: 10.3389/fendo.2021.652888] [Reference Citation Analysis]
5 Alla A, Draoui N, Rami I, Rouf S, Saadi H, Kamaoui I, Latrech H. A rare case report about a congenital adrenal hyperplasia by 21-hydroxylase lock in its pure virilizing form discovered in adolescence. Annals of Medicine and Surgery 2022;78:103673. [DOI: 10.1016/j.amsu.2022.103673] [Reference Citation Analysis]
6 Kim MS, Fraga NR, Minaeian N, Geffner ME. Components of Metabolic Syndrome in Youth With Classical Congenital Adrenal Hyperplasia. Front Endocrinol 2022;13:848274. [DOI: 10.3389/fendo.2022.848274] [Reference Citation Analysis]
7 Gomes LG, Mendonca BB, Bachega TASS. Long-term cardio-metabolic outcomes in patients with classical congenital adrenal hyperplasia: is the risk real? Curr Opin Endocrinol Diabetes Obes 2020;27:155-61. [PMID: 32304389 DOI: 10.1097/MED.0000000000000545] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 White PC. Update on diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Curr Opin Endocrinol Diabetes Obes 2018;25:178-84. [PMID: 29718004 DOI: 10.1097/MED.0000000000000402] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 5.3] [Reference Citation Analysis]
9 Improda N, Barbieri F, Ciccarelli GP, Capalbo D, Salerno M. Cardiovascular Health in Children and Adolescents With Congenital Adrenal Hyperplasia Due to 21-Hydroxilase Deficiency. Front Endocrinol (Lausanne) 2019;10:212. [PMID: 31031703 DOI: 10.3389/fendo.2019.00212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Paizoni L, Auer MK, Schmidt H, Hübner A, Bidlingmaier M, Reisch N. Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Steroid Biochem Mol Biol 2020;197:105540. [PMID: 31730799 DOI: 10.1016/j.jsbmb.2019.105540] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
11 Schröder MAM, van Herwaarden AE, Span PN, van den Akker ELT, Bocca G, Hannema SE, van der Kamp HJ, de Kort SWK, Mooij CF, Schott DA, Straetemans S, van Tellingen V, van der Velden JA, Sweep FCGJ, van der Grinten HLC. Optimizing the timing of highest hydrocortisone dose in children and adolescents with 21-hydroxylase deficiency. J Clin Endocrinol Metab 2021:dgab826. [PMID: 34788830 DOI: 10.1210/clinem/dgab826] [Reference Citation Analysis]
12 Kurnaz E, Çetinkaya S, Özalkak Ş, Bayramoğlu E, Demirci G, Öztürk HS, Erdeve ŞS, Aycan Z. Serum Fetuin-A and Insulin Levels in Classic Congenital Adrenal Hyperplasia. Horm Metab Res 2020;52:654-9. [PMID: 32108931 DOI: 10.1055/a-1116-2173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]